关注
Kranthi Kumar Chougoni MS/PhD
Kranthi Kumar Chougoni MS/PhD
Norris Cancer Center, University of Southern California,
在 med.usc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Curcumin and piperine abrogate lipid and protein oxidation induced by D-galactose in rat brain
D Banji, OJF Banji, S Dasaroju, KK Ch
Brain research 1515, 1-11, 2013
662013
Zingerone regulates intestinal transit, attenuates behavioral and oxidative perturbations in irritable bowel disorder in rats
D Banji, OJF Banji, B Pavani, CK Kumar, AR Annamalai
Phytomedicine 21 (4), 423-429, 2014
632014
Combination of carvacrol with methotrexate suppresses Complete Freund's Adjuvant induced synovial inflammation with reduced hepatotoxicity in rats
OJF Banji, D Banji, N Soumya, KK Chilipi, CH Kalpana, CHK Kumar, ...
European journal of pharmacology 723, 91-98, 2014
302014
CtBP—a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma
AT Chawla, KK Chougoni, PJ Joshi, AD Cororaton, P Memari, ...
Oncogenesis 8 (10), 55, 2019
202019
Extraction of high-quality RNA from mouse pancreatic tumors
KK Chougoni, SR Grossman
MethodsX 7, 101163, 2020
62020
Sensitizing oncogenic mutant p53-expressing non-small cell lung cancer to proteasome inhibitors
KK Chougoni, VL Neely, B Ding, E Oduah, K Nguyen, B Hu, J Koblinski, ...
Cancer Research 83 (7_Supplement), 3950-3950, 2023
22023
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
KK Chougoni, H Park, PK Damle, T Mason, B Cheng, MM Dcona, ...
Oncogenesis 12 (1), 53, 2023
12023
p38-p14ARF-CtBP2 axis as a novel regulator of CSC phenotype and tumor cell dormancy
RS Boothello, NJ Patel, PK Damle, C Sharon, KK Chougoni, UR Desai, ...
Cancer Research 78 (13_Supplement), 3460-3460, 2018
12018
Novel in-vitro and in-vivo strategies to study pancreatic ductal adenocarcinoma progression and chemoresistance
KK Chougoni
Frontiers in Cell and Developmental Biology 12, 1435209, 2024
2024
Orthogonal targeting of NAD metabolism and ErbB2/ErbB3 signaling in pancreatic adenocarcinoma
KK Chougoni, N Kim, MM Dcona, DT Dcona, GK Malhotra, SR Grossman
Cancer Research 84 (6_Supplement), 7217-7217, 2024
2024
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis
KK Chougoni, V Neely, B Ding, E Oduah, V Lam, B Hu, JE Koblinski, ...
bioRxiv, 2024.02. 22.581532, 2024
2024
Combined targeting of NAD biosynthesis and the NAD-dependent transcription factor C-terminal Binding Protein as a promising novel therapy for pancreatic cancer
MM Dcona, KK Chougoni, DT Dcona, JL West, SJ Singh, KC Ellis, ...
Cancer Research Communications 3 (10), 2003-2013, 2023
2023
C-terminal Binding Protein (CtBP): a critical regulator of ErbB2/3 signaling in PDAC.
KK Chougoni, H Park, PK Damle, MM Dcona, B Szomju, MG Dozmorov, ...
CANCER RESEARCH 82 (22), 106-106, 2022
2022
Investigating the role of oncogene C-terminal Binding Protein (CtBP) in Pancreatic Ductal Adenocarcinoma
KK Chougoni
2020
系统目前无法执行此操作,请稍后再试。
文章 1–14